• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Emergent BioSolutions

Emergent BioSolutions

  1. Research and Markets: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Research and Markets: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

  2. Emerging-Market Currencies Fall on Growing China Concerns

    Emerging-Market Currencies Fall on Growing China Concerns

  3. Reports Wand from Excel4apps Now Available with NoetixViews for Powerful Reporting Alternative to Oracle Discoverer

    Reports Wand from Excel4apps Now Available with NoetixViews for Powerful Reporting Alternative to Oracle Discoverer

  4. Research and Markets: Hemophilia A Pipeline Review, H1 2015 - 32 Companies & 39 Drug Profiles

    Research and Markets: Hemophilia A Pipeline Review, H1 2015 - 32 Companies & 39 Drug Profiles

  5. Research and Markets: H5N1 Infection (Avian Influenza) Pipeline Review 2015 - 42 Companies & 59 Drug Profiles

    Research and Markets: H5N1 Infection (Avian Influenza) Pipeline Review 2015 - 42 Companies & 59 Drug Profiles

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.